PetCure Oncology says it has now treated 10,000 radiation patients

PetCure Oncology said it has now treated 10,000 pets with radiation therapy since launching in 2015, a milestone the company is framing as evidence that advanced radiation oncology has moved beyond a small number of academic centers and into a broader referral network. In its January 7, 2026 announcement, the Thrive Pet Healthcare affiliate said it now operates eight treatment centers nationwide, supports referrals with 12 board-certified oncologists and eight supervising veterinarians, and treats about 1,000 patients a year. The company says its model has centered on expanding access to stereotactic radiosurgery and stereotactic radiation therapy, which can often be delivered in one to three sessions instead of the historical 15 to 20 fractions used in more conventional protocols. (petcureoncology.com)

Why it matters: For veterinary professionals, the milestone is less about a round number than what it says about referral infrastructure. Radiation therapy is still a limited resource in the U.S., with a 2024 Veterinary Cancer Society facilities list showing a relatively small national footprint and a 2024 review in Today's Veterinary Nurse noting 139 board-certified veterinary radiation oncologists in the U.S. as of December 2023. PetCure and other specialty providers have tried to narrow that access gap by building community-based treatment sites, telehealth consult pathways, and shorter stereotactic protocols that can make referral more realistic for pet parents who live hours from a center. (vetcancersociety.org)

What to watch: Watch whether PetCure’s newer technology rollout, including the planned Sirius platform launch in Seattle announced in November 2025, translates into additional sites, higher case volume, or broader treatment indications in 2026. (newswire.com)